FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080630526> ?p ?o ?g. }

• W3080630526 abstract "Abstract Background Studies have demonstrated that seropositive patients with rheumatoid arthritis (RA) are susceptible to cardiovascular diseases (CVDs). In this study, we aimed to determine the association of autoantibodies with the echocardiographic parameters of systolic and diastolic dysfunction in such patients. Methods In this cross-sectional study, we evaluated patients with RA who were referred to our clinic from October 2017 to August 2018. After the exclusion of patients with concomitant CVD, all patients underwent transthoracic echocardiography and measurement of plasma autoantibodies. Moreover, possible confounders—including medications, CVD risk factors, Framingham risk score, disease activity score-28, duration of disease, simple disease activity index, and functional status—were assessed. Results We studied 135 patients with RA (mean age = 52.3 years; 111 (82.2%) females). We had missing data rates of up to 8.9% for some characteristics. E velocity was inversely correlated with rheumatoid factor ( P = 0.009). Furthermore, the plasma levels of anti-citrullinated protein and anti-modified citrullinated vimentin (anti-MCV) antibodies were negatively correlated with left ventricular ejection fraction (LVEF) ( P = 0.019 and P <0.001, respectively). After an adjustment for possible confounders, the linear regression model demonstrated that the anti-MCV level and the patient’s age are significant predictors of LVEF. The receiver operating characteristic curve showed that anti-MCV antibody titer≥547.5 (IU/mL) signifies reduced LVEF (<50%) with a sensitivity of 85.7% and specificity of 93% (C-statistic = 0.843). Conclusions Our findings showed a significant inverse correlation between anti-MCV antibody titer and LVEF. These results indicate that the application of anti-MCV is promising for the screening and early detection of cardiac systolic dysfunction. Future prospective studies will determine its role." @default.
• W3080630526 created "2020-09-01" @default.
• W3080630526 creator A5040815365 @default.
• W3080630526 creator A5062037359 @default.
• W3080630526 creator A5068772116 @default.
• W3080630526 creator A5086068234 @default.
• W3080630526 date "2020-08-26" @default.
• W3080630526 modified "2023-09-27" @default.
• W3080630526 title "Anti-modified citrullinated vimentin antibody: a novel biomarker associated with cardiac systolic dysfunction in patients with rheumatoid arthritis" @default.
• W3080630526 cites W2004065584 @default.
• W3080630526 cites W2034908016 @default.
• W3080630526 cites W2042009497 @default.
• W3080630526 cites W2053489029 @default.
• W3080630526 cites W2100676028 @default.
• W3080630526 cites W2101693202 @default.
• W3080630526 cites W2103717403 @default.
• W3080630526 cites W2121229028 @default.
• W3080630526 cites W2144701759 @default.
• W3080630526 cites W2148092884 @default.
• W3080630526 cites W2155402987 @default.
• W3080630526 cites W2157810573 @default.
• W3080630526 cites W2287296412 @default.
• W3080630526 cites W2337203068 @default.
• W3080630526 cites W2513356558 @default.
• W3080630526 cites W2527939994 @default.
• W3080630526 cites W2581671608 @default.
• W3080630526 cites W2598953857 @default.
• W3080630526 cites W2755895428 @default.
• W3080630526 cites W2789912328 @default.
• W3080630526 cites W2790443016 @default.
• W3080630526 cites W2800826112 @default.
• W3080630526 doi "https://doi.org/10.1186/s12872-020-01676-x" @default.
• W3080630526 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7448352" @default.
• W3080630526 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32847506" @default.
• W3080630526 hasPublicationYear "2020" @default.
• W3080630526 type Work @default.
• W3080630526 sameAs 3080630526 @default.
• W3080630526 citedByCount "4" @default.
• W3080630526 countsByYear W30806305262021 @default.
• W3080630526 countsByYear W30806305262023 @default.
• W3080630526 crossrefType "journal-article" @default.
• W3080630526 hasAuthorship W3080630526A5040815365 @default.
• W3080630526 hasAuthorship W3080630526A5062037359 @default.
• W3080630526 hasAuthorship W3080630526A5068772116 @default.
• W3080630526 hasAuthorship W3080630526A5086068234 @default.
• W3080630526 hasBestOaLocation W30806305261 @default.
• W3080630526 hasConcept C126322002 @default.
• W3080630526 hasConcept C159654299 @default.
• W3080630526 hasConcept C163764329 @default.
• W3080630526 hasConcept C164705383 @default.
• W3080630526 hasConcept C185592680 @default.
• W3080630526 hasConcept C198451711 @default.
• W3080630526 hasConcept C203014093 @default.
• W3080630526 hasConcept C2776232647 @default.
• W3080630526 hasConcept C2777575956 @default.
• W3080630526 hasConcept C2778198053 @default.
• W3080630526 hasConcept C2781197716 @default.
• W3080630526 hasConcept C55493867 @default.
• W3080630526 hasConcept C555175668 @default.
• W3080630526 hasConcept C71924100 @default.
• W3080630526 hasConcept C77350462 @default.
• W3080630526 hasConcept C78085059 @default.
• W3080630526 hasConcept C90924648 @default.
• W3080630526 hasConceptScore W3080630526C126322002 @default.
• W3080630526 hasConceptScore W3080630526C159654299 @default.
• W3080630526 hasConceptScore W3080630526C163764329 @default.
• W3080630526 hasConceptScore W3080630526C164705383 @default.
• W3080630526 hasConceptScore W3080630526C185592680 @default.
• W3080630526 hasConceptScore W3080630526C198451711 @default.
• W3080630526 hasConceptScore W3080630526C203014093 @default.
• W3080630526 hasConceptScore W3080630526C2776232647 @default.
• W3080630526 hasConceptScore W3080630526C2777575956 @default.
• W3080630526 hasConceptScore W3080630526C2778198053 @default.
• W3080630526 hasConceptScore W3080630526C2781197716 @default.
• W3080630526 hasConceptScore W3080630526C55493867 @default.
• W3080630526 hasConceptScore W3080630526C555175668 @default.
• W3080630526 hasConceptScore W3080630526C71924100 @default.
• W3080630526 hasConceptScore W3080630526C77350462 @default.
• W3080630526 hasConceptScore W3080630526C78085059 @default.
• W3080630526 hasConceptScore W3080630526C90924648 @default.
• W3080630526 hasIssue "1" @default.
• W3080630526 hasLocation W30806305261 @default.
• W3080630526 hasLocation W30806305262 @default.
• W3080630526 hasLocation W30806305263 @default.
• W3080630526 hasOpenAccess W3080630526 @default.
• W3080630526 hasPrimaryLocation W30806305261 @default.
• W3080630526 hasRelatedWork W1491404397 @default.
• W3080630526 hasRelatedWork W1596297887 @default.
• W3080630526 hasRelatedWork W182203678 @default.
• W3080630526 hasRelatedWork W1999301958 @default.
• W3080630526 hasRelatedWork W2043104746 @default.
• W3080630526 hasRelatedWork W2428581596 @default.
• W3080630526 hasRelatedWork W2557248628 @default.
• W3080630526 hasRelatedWork W2581494937 @default.
• W3080630526 hasRelatedWork W3017073535 @default.
• W3080630526 hasRelatedWork W3027423528 @default.
• W3080630526 hasVolume "20" @default.
• W3080630526 isParatext "false" @default.
• W3080630526 isRetracted "false" @default.
• W3080630526 magId "3080630526" @default.

• next